118 related articles for article (PubMed ID: 7537626)
1. Serum CD44 splice variants in cervical cancer patients.
Kainz C; Tempfer C; Winkler S; Sliutz G; Koelbl H; Reinthaller A
Cancer Lett; 1995 Apr; 90(2):231-4. PubMed ID: 7537626
[TBL] [Abstract][Full Text] [Related]
2. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
3. Soluble CD44 standard, CD44 variant 5 and CD44 variant 6 and their relation to staging in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Ozeki A; Kokatsu T; Kubota A; Furukawa M; Tsukuda M
Acta Otolaryngol; 2005 Apr; 125(4):392-7. PubMed ID: 15823810
[TBL] [Abstract][Full Text] [Related]
4. The serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant 5 (sCD44-v5), and CD44 splice variant 6 (sCD44-v6) in patients with cervical cancer.
Gadducci A; Ferdeghini M; Cosio S; Annicchiarico C; Fanucchi A; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1998; 18(1B):537-9. PubMed ID: 9568174
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of soluble adhesion molecules CD44 (CD44st, CD44v5, CD44v6), ICAM-1, and VCAM-1 as tumor markers in head and neck cancer.
Kawano T; Yanoma S; Nakamura Y; Shiono O; Kokatu T; Kubota A; Furukawa M; Tsukuda M
Am J Otolaryngol; 2005; 26(5):308-13. PubMed ID: 16137528
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of CD44 splice variants in human stage III cervical cancer.
Kainz C; Kohlberger P; Tempfer C; Sliutz G; Gitsch G; Reinthaller A; Breitenecker G
Eur J Cancer; 1995 Sep; 31A(10):1706-9. PubMed ID: 7488429
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of the human metastasis adhesion molecule CD44V in normal and carcinomatous stomach mucosa of Chinese subjects.
Harn HJ; Ho LI; Chang JY; Wu CW; Jiang SY; Lee HS; Lee WH
Cancer; 1995 Mar; 75(5):1065-71. PubMed ID: 7531611
[TBL] [Abstract][Full Text] [Related]
8. [CD44 splice variants as prognostic factors in invasive cervix carcinoma].
Reinthaller A; Kainz C; Kohlberger P; Tempfer C; Gitsch G; Kölbl H; Breitenecker G
Gynakol Geburtshilfliche Rundsch; 1995; 35(1):16-9. PubMed ID: 7537136
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical detection of adhesion molecule CD44 splice variants in lymph node metastases of cervical cancer.
Kainz C; Tempfer C; Kohlberger P; Janisch S; Koelbl H; Gitsch G; Breitenecker G
Int J Cancer; 1996 Jun; 69(3):170-3. PubMed ID: 8682582
[TBL] [Abstract][Full Text] [Related]
10. Increased serum levels of soluble CD44 standard, but not of variant isoforms v5 and v6, in B cell chronic lymphocytic leukemia.
De Rossi G; Marroni P; Paganuzzi M; Mauro FR; Tenca C; Zarcone D; Velardi A; Molica S; Grossi CE
Leukemia; 1997 Jan; 11(1):134-41. PubMed ID: 9001429
[TBL] [Abstract][Full Text] [Related]
11. CD44 variant exon epitopes in primary breast cancer and length of survival.
Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
[TBL] [Abstract][Full Text] [Related]
12. CD44 is an independent prognostic factor in early-stage cervical cancer.
Speiser P; Wanner C; Tempfer C; Mittelböck M; Hanzal E; Bancher-Todesca D; Gitsch G; Reinthaller A; Kainz C
Int J Cancer; 1997 Apr; 74(2):185-8. PubMed ID: 9133453
[TBL] [Abstract][Full Text] [Related]
13. Surface protein expression and messenger RNA-splicing analysis of CD44 in uterine cervical cancer and normal cervical epithelium.
Dall P; Heider KH; Hekele A; von Minckwitz G; Kaufmann M; Ponta H; Herrlich P
Cancer Res; 1994 Jul; 54(13):3337-41. PubMed ID: 7516819
[TBL] [Abstract][Full Text] [Related]
14. Levels of v5 and v6 CD44 splice variants in serum of patients with colorectal cancer are not correlated with pT stage, histopathological grade of malignancy and clinical features.
Zalewski B
World J Gastroenterol; 2004 Feb; 10(4):583-5. PubMed ID: 14966921
[TBL] [Abstract][Full Text] [Related]
15. CD44 variant expression is a common feature of epithelial ovarian cancer: lack of association with standard prognostic factors.
Cannistra SA; Abu-Jawdeh G; Niloff J; Strobel T; Swanson L; Andersen J; Ottensmeier C
J Clin Oncol; 1995 Aug; 13(8):1912-21. PubMed ID: 7543560
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical and serological evaluation of CD44 splice variants in human ovarian cancer.
Sliutz G; Tempfer C; Winkler S; Kohlberger P; Reinthaller A; Kainz C
Br J Cancer; 1995 Dec; 72(6):1494-7. PubMed ID: 8519665
[TBL] [Abstract][Full Text] [Related]
17. Expression of CD44 splice variants during lymphocyte activation and tumor progression.
Griffioen AW; Horst E; Heider KH; Wielenga VJ; Adolf GR; Herrlich P; Pals ST
Cell Adhes Commun; 1994 Jul; 2(3):195-200. PubMed ID: 7530151
[TBL] [Abstract][Full Text] [Related]
18. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
19. CD44 splice variants as prognostic markers in colorectal cancer.
Wielenga VJ; van der Voort R; Mulder JW; Kruyt PM; Weidema WF; Oosting J; Seldenrijk CA; van Krimpen C; Offerhaus GJ; Pals ST
Scand J Gastroenterol; 1998 Jan; 33(1):82-7. PubMed ID: 9489913
[TBL] [Abstract][Full Text] [Related]
20. Serum assay of soluble CD44 standard (sCD44-st), CD44 splice variant v5 (sCD44-v5), and CD44 splice variant v6 (sCD44-v6) in patients with epithelial ovarian cancer.
Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Cosio S; Prontera C; Bianchi R; Genazzani AR
Anticancer Res; 1997; 17(6D):4463-6. PubMed ID: 9494551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]